Skip to main content
logo
Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ: BDTX · Real-Time Price · USD
2.030
+0.050 (2.53%)
Sep 14, 2026, 2:06 PM EDT - Market open

BDTX Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-42.5622.37-69.68-82.44-91.17-125.6
Depreciation & Amortization
0.210.330.340.440.510.21
Loss (Gain) From Sale of Assets
-0-0.03-0.090.36-2.230
Asset Writedown & Restructuring Costs
7.357.35----
Loss (Gain) From Sale of Investments
-0.84-1.35-3.78-1.170.542.18
Loss (Gain) on Equity Investments
----2.25-
Stock-Based Compensation
6.116.6310.639.612.214.04
Other Operating Activities
2.63.052.972.812.732.01
Change in Accounts Payable
0.63-3.431.680.6-2.231.57
Change in Other Net Operating Assets
-6.33-5.3-4.383.09-7.675.45
Operating Cash Flow
-32.8429.61-62.3-66.72-85.08-100.15
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
----0.03-0.19-2.71
Sale of Property, Plant & Equipment
00.030.090.10.01-
Investment in Securities
22.07-44.9316.8716.2853.55133.32
Investing Cash Flow
22.08-44.9116.9716.3553.37130.61

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
0.03-25.5571.930.180.73
Repurchase of Common Stock
-0.06-0.15----
Financing Cash Flow
-0.03-0.1525.5571.930.180.73

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-10.79-15.44-19.7921.56-31.5431.19

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-32.8429.61-62.3-66.75-85.27-102.86
Free Cash Flow Growth
------
Free Cash Flow Margin
-42.31%----
Free Cash Flow Per Share
-0.570.51-1.13-1.52-2.35-2.84
Levered Free Cash Flow
-23.5813.03-37.6-37.65-55.39-59.04
Unlevered Free Cash Flow
-23.5813.03-37.6-37.65-55.39-59.04

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
-5.7-8.73-2.693.69-9.97.02
SEC Filings: 10-K · 10-Q